Figure 5. CEACAM in vivo binding.
[125I]-Labelled T84.1 and nonspecific [125I]-labelled IgG1 antibody were used for CEACAM in vivo binding in FemX-1 melanoma bearing SCID mice. There is a significant difference between specific and control antibody by FemX-1 melanoma, but not in other organs including blood (Two-way ANOVA, P<0.001, nā=ā6).